Dr. George Golumbeski joins Peptone as Board and Executive Advisor
Biopharmaceutical dealmaker Dr. George Golumbeski joined Peptone as a Board and Executive Advisor
Dr. George Golumbeski joined Peptone as a Board and Executive Advisor.
Dr. Golumbeski is an experienced biopharmaceutical dealmaker. He previously served as Executive Vice President of Business Development at Celgene, where he was responsible for collaborations with biotechnology companies developing medicines for cancer and chronic inflammation.
He has since focused on new company creation and has served on the boards of several biotechnology companies, including:
- KSQ Therapeutics
- Enanta Pharmaceuticals
- MorphoSys
- Sage Therapeutics
His appointment brought Peptone additional experience in business development, company building, and strategic biotechnology partnerships.